Merck KGaA, the German maker of Erbitux cancer medicine, promoted Stefan Oschmann to deputy chief executive officer and appointed Belen Garijo as its first female board member. Oschmann, currently head of the pharmaceutical unit, and Garijo, now ... BusinessWeek, 2 months ago
Merck KGaA Names Pharmaceutical Chief Oschmann as Deputy CEO - Washington Post, 2 months ago
ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, 744TiP, 745TiP; further pipeline: 772P, 507PD, 1235P ...Newswit.com, 1 month ago Merck KGaA : Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of Precision Medicine in Cancer Care 4 Traders, 1 month ago Merck on Track with Pharma Strategy Bionity.com, 2 months ago Merck KGaA : on Track with Pharma Strategy; Pipeline Progress Announced 4 Traders, 2 months ago
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ERBITUX CETUXIMAB" by Robert E. Lee , Jr., representing ...4 Traders, 1 month ago Researchers Submit Patent Application, "Predicting Response to Egfr Inhibitors", for Approval 4 Traders, 2 weeks ago Genovis : Researchers Submit Patent Application, "Endoglycosidase from Streptococcus Pyogenes and Methods Using It", for Approval 4 Traders, 1 month ago
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of ...Global Information Inc, 2 weeks ago
Former Executive Director, Section Head Oncology Clinical Development at Merck & Co., Inc. and Director of Erbitux Medical Strategy at Bristol-Myers Squibb to Oversee Advaxis's Clinical Programs PRINCETON, N.J., Oct. 20, 2014 (GLOBE NEWSWIRE) -- ...Securities Technology Monitor, 1 month ago Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer FierceBiotech, 4 weeks ago Advaxis, Inc. Appoints As Chief Medical Officer BioSpace, 1 month ago Advaxis : Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer 4 Traders, 1 month ago
TrovaGene, Inc. ( TROV ) recently unveiled clinical study results that reflect the capability of its Precision Cancer Monitoring technology in detecting and monitoring KRAS mutation in circulating tumor DNA (ctDNA). The study compared the amount ...Yahoo! Finance, 1 day ago
Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients
BARCELONA , Nov. 20, 2014 /PRNewswire/ --Trovagene, Inc., ( NASDAQ: TROV ) a developer of cell-free molecular diagnostics, announced today clinical study results highlighting the Company's ability to detect and quantitate KRAS mutations in blood and ...SearchBug, 2 days ago TROVAGENE : Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients 4 Traders, 1 day ago TrovaGene, Inc. Releases Clinical Study Results For The Detection And Monitoring Of KRAS Mutations In Circulating Tumor DNA Of Colorectal Cancer Patients BioSpace, 2 days ago
Nancy, France, le 20 novembre 2014 : Genclis, société de diagnostic moléculaire dans les domaines de l'allergie et du cancer, sera présente les 22 et 23 novembre prochains aux 2èmes Rencontres Francophones d'Allergologie Moléculaire à Paris ( ...Sante Log, 2 days ago Genclis SAS Coordinate a Roundtable in a Molecular Allergology Seminar Financial Content, 2 days ago
Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S.
WASHINGTON , Nov. 20, 2014 /PRNewswire-USNewswire/ --In recognition of decades of medical progress in the country's fight against cancer, a national group of healthcare stakeholders called the Cancer Innovation Coalition (CIC) today launched the ...RCL Advisors, 2 days ago
Christine McSherry's son Jett is a typical college freshman trying to push for as much independence as he can. But Duchenne muscular dystrophy, a disease that tears away muscles, has taken his ability to walk. He relies dailyon aides to help ...US News & World Report, 4 days ago
on your WebpageAdd Widget >Get your members hooked!